Iratumumab (MDX-060) a human anti-CD30 IgG1kappa monoclonal antibody. Iratumumab inhibits the growth of CD30-expressing tumor cells. Iratumumab can be used for research of Hodgkins lymphoma (HL) and anaplastic large-cell lymphoma (ALCL)[1].
Molecular Weight:
(142.9 kDa)
Purity:
98.95
CAS Number:
[640735-09-7]
Target:
TNF Receptor
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted